Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling
Saved in:
| Published in: | 3 Biotech |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868553668474699778 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | 3 Biotech |
| description | |
| discipline_display | Biotechnology |
| discipline_facet | Biotechnology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:80979 |
| institution | FRELIP |
| journal_source_facet | 3 Biotech |
| last_indexed | 2026-06-20T21:40:39.654Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling Biotechnology General Biotechnology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Biotechnology General Biotechnology |
| subject_facet | Biotechnology General Biotechnology |
| title | Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling |
| title_alt | Sinergia alogliptina-metformina mejora la pérdida ósea asociada a diabetes mediante modulación de la actividad DPP-4 y la señalización OPG/RANKL Synergie alogliptine-metformine améliore la perte osseuse associée au diabète via la modulation de l'activité DPP-4 et de la signalisation OPG/RANKL Sinergia alogliptina-metformina melhora a perda óssea associada ao diabetes via modulação da atividade de DPP-4 e sinalização OPG/RANKL |
| title_auth | Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling |
| title_es_txt | Sinergia alogliptina-metformina mejora la pérdida ósea asociada a diabetes mediante modulación de la actividad DPP-4 y la señalización OPG/RANKL |
| title_fr_txt | Synergie alogliptine-metformine améliore la perte osseuse associée au diabète via la modulation de l'activité DPP-4 et de la signalisation OPG/RANKL |
| title_full | Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling |
| title_fullStr | Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling |
| title_full_unstemmed | Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling |
| title_pt_txt | Sinergia alogliptina-metformina melhora a perda óssea associada ao diabetes via modulação da atividade de DPP-4 e sinalização OPG/RANKL |
| title_short | Alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of DPP-4 activity and OPG/RANKL signaling |
| title_sort | alogliptin-metformin synergy ameliorates diabetes-associated bone loss via modulation of dpp-4 activity and opg/rankl signaling |
| topic | Biotechnology General Biotechnology |
| url | https://link.springer.com/article/10.1007/s13205-026-04889-7 |